NZ771657A - Inhibition of cytokine-induced sh2 protein in nk cells - Google Patents

Inhibition of cytokine-induced sh2 protein in nk cells

Info

Publication number
NZ771657A
NZ771657A NZ771657A NZ77165716A NZ771657A NZ 771657 A NZ771657 A NZ 771657A NZ 771657 A NZ771657 A NZ 771657A NZ 77165716 A NZ77165716 A NZ 77165716A NZ 771657 A NZ771657 A NZ 771657A
Authority
NZ
New Zealand
Prior art keywords
inhibition
cells
cis
cytokine
induced
Prior art date
Application number
NZ771657A
Inventor
Nicholas D Huntington
Sandra E Nicholson
Jeff Babon
Tatiana Kolesnik
Original Assignee
Walter & Eliza Hall Inst Medical Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2015905220A external-priority patent/AU2015905220A0/en
Application filed by Walter & Eliza Hall Inst Medical Res filed Critical Walter & Eliza Hall Inst Medical Res
Publication of NZ771657A publication Critical patent/NZ771657A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to therapeutic and prophylactic methods based on inhibition of CIS in NK cells. In particular, the present invention relates to treating or preventing a NK-responsive condition by administering to a subject a CIS inhibitor, or administering CIS-inhibited NK cells. The invention further relates to methods for identifying a CIS inhibitor, and for determining a likelihood of cancer response to treatment with CIS inhibition.
NZ771657A 2015-12-16 2016-12-16 Inhibition of cytokine-induced sh2 protein in nk cells NZ771657A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2015905220A AU2015905220A0 (en) 2015-12-16 Methods of treatment
NZ74319116 2016-12-16

Publications (1)

Publication Number Publication Date
NZ771657A true NZ771657A (en) 2022-08-26

Family

ID=83229143

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ771657A NZ771657A (en) 2015-12-16 2016-12-16 Inhibition of cytokine-induced sh2 protein in nk cells

Country Status (1)

Country Link
NZ (1) NZ771657A (en)

Similar Documents

Publication Publication Date Title
EP4253412A3 (en) Inhibition of cytokine-induced sh2 protein in nk cells
PH12019501575A1 (en) ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFá1 INHIBITORS AND USE THEREOF
MX2021014709A (en) Methods for increasing red blood cell levels and treating sickle-cell disease.
MX2017003933A (en) Methods of treating liver disease.
PH12018500322A1 (en) Methods of treating cancer patients with farnesyltransferase inhibitors
PH12021550052A1 (en) Methods of treating and preventing graft versus host disease
MX2019007256A (en) Phosphodiesterase inhibitors and methods of microbial treatment.
MX2017005258A (en) Combination therapy for treatment of disease.
MX2017000307A (en) Treatment of leukemia with histone deacetylase inhibitors.
PH12020550936A1 (en) Combination drug including tlr7 agonist
MX2020011772A (en) Combination therapy involving antibodies against claudin 18.2 for treatment of cancer.
ZA201802966B (en) Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting agents for cancer treatment
WO2017177179A9 (en) Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases
MX2018016057A (en) Compositions and methods for treating cardiovascular disease.
PH12016500270A1 (en) Combination of a mek inhibitor and an erk inhibitor for use in treatment of hyperproliferative diseases
MX2022007436A (en) Autotaxin inhibitors and uses thereof.
MX2019005402A (en) Arginase inhibitor combination therapies.
EA201591278A1 (en) COMPOSITIONS CONTAINING C1-INH, AND METHODS OF PREVENTION AND TREATMENT OF DISORDERS ASSOCIATED WITH THE DEFICIENCY C1 inhibitor
MY190411A (en) Improved uricase sequences and methods of treatment
MX2020013808A (en) Gremlin-1 antagonist for the prevention and treatment of cancer.
MX2018008732A (en) Inhibition of allergic reaction using an il-33 inhibitor.
WO2019040106A3 (en) Compounds, salts thereof and their use in the treatment of diseases
MX2017009246A (en) Combination drug.
WO2017035176A8 (en) Method of preventing or treating obesity with an emc10 inhibitor
MX2017011018A (en) Inhibition of olig2 activity.

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 16 DEC 2024 BY RENEWALSDESK LIMITED

Effective date: 20231017